Академический Документы
Профессиональный Документы
Культура Документы
PIH
as the
INCIDENCE
5
percent to 8 percent of all pregnancies. Young women First pregnancy Twin pregnancies Previous pre-eclmaptic pregnancy Diabetese Mallitus Chronic hypertension
Types
PIH
Pre-eclampsia
(Toxemia of pregnancy)
Mild Severe
Eclampsia HELLP
syndrome
PIH
MILD
BP 140/90
SEVERE
BP 160/110 or more
Characteristics of Pre-Eclampsia
Hypertension
Protienuria
Edema
PRIMARY CHARACTERISTICS
High
blood pressure 140/90 mm Hg or a significant increase in one or both pressures Proteinuria (300 mg or >/24 hours urine)
Or Urinolysis +++ or ++++
Edema
ECLAMPSIA
Severe
form of PIH Women with eclampsia have seizures Occurance one in 1,600 pregnancies Develops near the end of pregnancy, in most cases.
HELLP syndrome
Complication
of severe pre-eclampsia or
eclampsia. group of physical changes: Breakdown of RBCs, Changes in the liver Low platelets
HELLP
H:
HELLP
Diagnosis
Hemolysis
Blood smear
Bilirubin 1.2 mg/dl or more
Elevated
liver enzymes
SGOT (asperate aminotransferase) > 70 U/L Lactate dehydrogenase > 600 U/L
Low
Platelets
<100,000 per mm3
cause of PIH
unknown ???
Pathophysiology
Immunologic
response Endothelial Dysfunction Abnormal Prostaglandin Metabolism Platelet Dysfunction Calcium Coagulation factors Fatty metabolism Markers of angiogenesis
1-Immunologic response
Abnormal fetal-maternal antigen-antibody response Spermatozoa cause formation antibody or prostaglandins which cause VC Normally at 20 weeks, Maternal spiral arteries are invaded by trophoblast causing release of PGI and NO, this mechanism lacks in pre eclampsia >>>>high resistance low flow uteroplacental circulation
in response to unknown factors Resulting in imbalance in the production of :PGI2 and EDRF(NO) >> Vasodialator & :TXA2 derived from platelets & endothelaium >>Vasoconstrictor ET-1: chorionic plate arteries constrictor, elevated in pre-eclampsia & pre term rupture of membrane
Platelet factor
Normally aggregating platelet release (serotonin) 5HT + 5HT receptors >> release of NO & Prostacyclin >> Angiotensin II >> improve uteroplacental blood flow
Loss
CALCIUM
Instead of normal slow rise of intracellular Calcium concentration In Pre eclampsia Ca++ increases rapidly also enhanced by angiotensin II
Other Factors
Coagulation factors disturbance between plasma ratio of von Willebrand factor and factor VIII Fatty metabolism increased free fatty uptake by liver hypertriglyceridemia Markers of angiogenesis FLT-I, VEGF (vascular endothelial growth factor)
hypertension kidney disease Diabetes Mallitus PIH with a previous pregnancy Mother's age younger than 20 or older than 40 multiple fetuses (twins, triplets) Vascular Diseases
With high blood pressure there is an increase in the resistance of blood vessels. This may hinder blood flow in many different organ systems in the expectant mother including the liver, kidneys, brain, uterus, and
placenta.
Complications
Maternal
DIC CCF with pulmonary edema Placental Abruption
Fetal
Pre-maturity Respiratory Distress IUG retardation
PPH
ARF Rupture of Liver
Oligohydromnios
Intracranial Hemorrhage Small for age
CVA, Seizures
Septic shock
Meconium aspiration
More Morbidity/Mortality
Symptoms of PIH
Neurological
Headach, Hyperexcitability, Intracranail hemorrhages, Visual distubances Seizers Cerebral edema
Pulmonary
Cardiovascular
Hepatic
Renal Hematological
goal of treatment
To prevent the: Condition from becoming bad to worse Complications.
Obstetric Management
Bedrest (either at home or in the hospital) Hospitalization (specialized personnel and equipment) Magnesium sulfate (or other antihypertensives for PIH) Fetal monitoring may include: fetal movement counting - fetal kicks and movements change in the number/frequency: means fetus under stress. nonstress testing - measures the fetal heart rate in response to the fetus' movements. biophysical profile - combines nonstress test with ultrasound Doppler flow studies Continued laboratory testing of urine and blood (for changes that may signal worsening of PIH) Corticosteroids (help mature the lungs of the fetus) Delivery of the baby (if treatments do not control PIH or if the fetus or mother is in danger)
ANTIHYPERTENSIVES
Diuretic Beta Blocker ACE inhibitors Calcium /Angiotensin II receptor Channel Blocker antagonist Alpha Blockers
Caution
No Adversely effect fetal and neonatal blood pressure control, skull defects, oligohydromnios, toxicity
No Myocardial depressants
caution
Labetalol
Arteriolar dilator I/V Max 200 mg 2mg/min until satisfactory response Oral 200 mg BID upto 1200mg Vasodilator Causes tachycardia fluid retention Oral 25 mg BD IV 10mg in 10 ml saline in 20 minutes Isorbid dinitrate, Glyceryl trinitrate, isorbid mono nitrate
Hydralazine
(Apresoline)
Nitrates
Methyldopa
(Aldomet)
Alpha methyldopa 500 mg PO bid (up to 2 grams bid) Labetolol 200 mg PO bid (up to 1200 mg bid) Felodipine 5 mg PO daily (up to 20 mg daily) Hydrochlorothiazide
Not usually initiated in pregnancy due to volume depletion May be continued if on pre-pregnancy - consult with local expert opinion
GOAL
of
Antihypertensives
Blood
Anti-hypertensives are not indicated for mild to moderate chronic Hypertension in pregnancy
BP
Pre-Operative Evaluation
Investigations ?
Blood complete picture Platelet count Coagulation assay, PT, APTT, Fibrinogen, D - dimer Serum Urea/creatinine Electrolytes Uric Acid LFTs Urinolysis, Microscopy, 24 Hours specimen for protien and creatinine clearence Type and screen Blood
Monitors
NIBP SaO2 Hourly deep tendon reflex Muscle strength Serial Magnesium Sulphate levels Foleys Catheter for urine volume Urine concentration Fetal heart Rate IBP CVP Persistent oligouria, difficulty in fluid management therapy in ante/post partum period, Pulmonary edema PA Severe eclampsia Left ventricular systolic function is markedly reduced CVP 92% versus PA 8%
Immediate Delivery
Severe
Hypertension Progressive thrombocytopenia Liver dysfunction Progressive Renal dysfunction Persistent headache Evidence of fetal jeopardy Premonitory signs of ECLAMPSIA
Magnesium
Sulphate
Loss of deep tendon reflexes Prolonged P-Q interval Widening QRS complexes
15 mEq/L 20 mEq/L
CNS depressant & Anticonvulsant CVS Mild Anti-hypertensive effect Neuromuscular Junction
Inhibits Ach release decrease membrane excitability augment Non and depolarizing muscle relaxant
Uterus
Mild relaxant effect on vascular & uterine smooth muscle Improve uterine blood flow
Neonatal depression
Respiratory Hyporeflexia Decreased beat to beat variability in heart rate
Treatment of Eclampsia
Stop convulsion (Thiopentone 50-100 mg) ABC Apply monitors (Pulse Oximeter, NIBP, ECG) I/V line Check BP repeatedly Administer MgSO4 Treat hypertension Deliver baby
Intraoperative Management
What type?
Superior pain relief Attenuate the hypertensive response to pain Reduce circulating level of catecholamines/hormones Improve intervillous blood flow Stable Cardiac output Increased Risk for C-section
Prehydration with crystalloid compensate for decreased prelaod and after laod >>> ANP >> VD >>renal elimination of excess ECF AVOID if there is recent excessive weight gain (overhydration) Monitor for pulmonary oedema
not useful
Skin bleeding time is not predictor for preeclamptic epidural vein bleeding
Platelet
count reliable
50-80,000
Bupivacain
4 times potent then lignocain Onset 5 times longer then lignocain Fast in, slow out
Ropivacain
Single levorotatory isomer rather then racemic solution Less cardiotoxic
Levobupivacain
Single levorotatory isomer Less cardiotoxic
Lignocain
More Motor block More hypotension instant onset
Note: with adrenaline should not be used in severe preeclampsia
Spinal
General
Spinal Anaesthesia
Best even in severe pre-eclampsia GA Severe hypertensive response to intubation Risk of difficult intubation due to airway edema Epidural Less reliable anaesthesia than spinal Risk of trauma to epidural vein Risk of hypotension 6 times less in pre eclamptic pregnant woman .75% hyperbaric Bupivacain 11-12 mg with or without 15-20 g Fentanyl or morphine 100-200 g
General Anesthesia
Aspiration prophylaxis Thiopentone sodium induction Suxamethonium with cricoid pressure Attenute intubation response by deep anaesthesia & lignocain Smaller ETT 6-6.5 mm (airway edema) Nondepolarizing agent after recovery from suxamethonium Remember MgSO4 2/3 rd MAC for adequate depth of anaesthesia MgSO4 intra and Post op period IBP line for continuous blood pressure monitoring Anti HTN drugs
The End